Goldfine, A. B., Jablonski, K. A., Shoelson, S. E., & Creager, M. A. (2014). Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139. Diabetes Care.

Goldfine, Allison B., Kathleen A. Jablonski, Steven E. Shoelson, und Mark A. Creager. "Response to Comment On Goldfine Et Al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects On Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139." Diabetes Care 2014.

Goldfine, Allison B., Kathleen A. Jablonski, Steven E. Shoelson, und Mark A. Creager. "Response to Comment On Goldfine Et Al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects On Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139." Diabetes Care 2014.